Brian Cherry Insider Profile
4 Followers
Brian Cherry, Director at Atara Biotherapeutics, holds 166.49K shares in Atara Biotherapeutics (Ticker: ATRA), holds 0.00 shares in Ignite (Ticker: IRGTQ), holds ― shares in Zymeworks (Ticker: ZYME). Most recently, Brian Cherry Bought ― shares of Atara Biotherapeutics on Sep 04, 2026 for an estimated value of $999.99K.
Brian Cherry has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Cherry holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brian Cherry
Brian Cherry's Trading History
Atara Biotherapeutics
Sep 04, 2026
Director
Informative Buy
999.99K
$1.57M
Ignite
―
―
―
$0.00
Zymeworks
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Brian Cherry's performance on stock
You May Also Like
Brian Cherry insider profile FAQ
What is the percentage of profitable transactions made by Brian Cherry?
The percentage of profitable transactions made by Brian Cherry is ―.
What is the average return per transaction made by Brian Cherry?
The average return per transaction made by Brian Cherry is ―.
What stocks does Brian Cherry hold?
Brian Cherry holds: ATRA, IRGTQ, ZYME stocks.
What was Brian Cherry’s latest transaction?
Brian Cherry latest transaction was an Informative Buy of $999.99K.
What was Brian Cherry's most profitable transaction?
Brian Cherry’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brian Cherry's role in Atara Biotherapeutics?
Brian Cherry's role in Atara Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.